We have analysed the haematological parameters in 21 patients with Shw
achman-Diamond syndrome (SDS) seen over a 25-year period at our instit
ution. Neutropenia, although present in all patients, was intermittent
in two-thirds, constant in the rest and was associated with impaired
chemotaxis in all of those patients tested. Fetal haemoglobin (HbF) wa
s elevated in 80% of the patients at some stage, and anaemia and throm
bocytopenia was documented in 66% and 24% respectively. Bone marrow sa
mples were taken in over half of the patients. Myelodysplastic syndrom
e (MDS) developed in seven (33%) patients, five of whom had acquired c
lonal structural chromosome abnormalities in their bone marrows. In fi
ve of the patients with RADS (24%) transformation to acute myeloid leu
kaemia occurred. Like other constitutional bone marrow failure syndrom
es, SDS has a predilection to leukaemic transformation hitherto assume
d to be in the region of 5-10%. The data presented here suggest that t
his figure probably represents an underestimate. Shwachman-Diamond syn
drome is an interesting model of leukaemia development and greater und
erstanding of the clinical spectrum of this rare disorder should produ
ce further insights into its pathobiology.